Medical Xpress news
Medical Xpress / AI tool shows promise in diagnosing advanced heart failure
Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, ...
Medical Xpress / From pathology image to biological discovery: LazySlide uses foundation models to connect tissue images and RNA data
Microscopic images of human tissue are a cornerstone of biomedical research and clinical diagnostics. Yet despite their importance, these images often remain difficult to analyze systematically and to connect with other types ...
Medical Xpress / Stability of brain's internal compass may help explain how memories last
A new discovery by McGill researchers sheds light on how we retain memories over time, even though brain activity is constantly changing. Published in Nature, the preclinical study found the brain's internal compass remains ...
Medical Xpress / Genes tied to impulse control play a major role in addiction risk
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences—not from genes that specifically influence substance ...
Medical Xpress / Deep learning model predicts how individual cells influence disease outcomes
A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to patient outcomes using widely available bulk RNA sequencing data. The approach uses single-cell reference ...
Medical Xpress / Home-based chemotherapy: Pilot study demonstrates safety and feasibility
In a study published in NEJM Catalyst, Mayo Clinic researchers demonstrate that chemotherapy can be safely delivered in patients' homes. The study evaluated Mayo Clinic's Cancer CARE Beyond Walls (Connected Access and Remote ...
Medical Xpress / Weight-loss drug semaglutide does not slow Alzheimer's disease, two clinical trials find
Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the first large Phase III randomized controlled trials on the topic published in The Lancet.
Medical Xpress / Large imaging study changes understanding of the origins of Parkinson's rest tremor
A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In contrast, tremor appears to be associated with relatively better-preserved dopamine function. Researchers ...
Medical Xpress / Digital decision support tool proven to reduce risks in bowel surgery
Recent research provides robust evidence for the use of a digital visualization and decision support tool in colorectal (bowel) surgery. This is the first time that a digital decision support tool has been conclusively proven ...
Medical Xpress / Botox: A new therapeutic approach to treating finger ulcers and gangrene
Injections of botulinum toxin, commonly known as Botox, could be an effective and well-tolerated option for treating debilitating complications caused by reduced blood flow to the fingers, such as acute digital ischemia (which ...
Medical Xpress / Promising active substance against hepatitis E identified
Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound ...
Medical Xpress / Diabetes outcomes worsen after insurance loss, study finds
Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University.
